In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Orion and Abbott expand collaboration for injectable levosimendan
Refocus Group reacquires rights to implant and surgical procedure from CIBA Vision
Orion Pharma gains rights to Nestorone in transdermal gels
D-Pharm reacquires DP-VPA from Shire
Peregrine Reacquires Rights to Oncolym
Orion grants GTx exclusive rights in the US for toremifene
Cephalon Reacquires Rights to Modafinil in Major European Markets
Orion has decided not to continue the development of a new COMT inhibitor candidate
Coulter reacquires Bexxar rights
ACRUX ENTERS COMMERCIAL MANUFACTURING ALLIANCE WITH ORION CORPORATION
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
